… sonidegib can be used to achieve clinical efficacy and avoid potential adverse events associated with drug toxicity. Interestingly, the adaptive immune response is promoted in patients with aBCC treated with sonidegib or vismodegib. Immunological markers, including Ber-Ep4, BCL-…